Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
- PMID: 11144371
- DOI: 10.1097/00006454-200012000-00002
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up
Abstract
Background: Several disorders have been attributed to measles-mumps-rubella (MMR) vaccination during the past decade. The aim of this prospective follow-up study was to identify serious adverse events causally related to MMR vaccination.
Methods: When the MMR vaccination program was launched in Finland in 1982, a countrywide surveillance system was set up to detect serious adverse events associated with MMR. To obtain detailed case histories vaccinees' clinical charts were reviewed. Serum samples were analyzed to trace concurrent infections.
Setting: All hospitals and health centers in Finland from 1982 through 1996.
Results: Immunization of 1.8 million individuals and consumption of almost 3 million vaccine doses by the end of 1996 gave rise to 173 potentially serious reactions claimed to have been caused by MMR vaccination. In all, 77 neurologic, 73 allergic and 22 miscellaneous reactions and 1 death were reported, febrile seizure being the most common event. However, 45% of these events proved to be probably caused or contributed by some other factor, giving an incidence of serious adverse events with possible or indeterminate causal relation with MMR vaccination of 5.3 per 100,000 vaccinees or 3.2 per 100,000 vaccine doses.
Conclusions: Causality between immunization and a subsequent untoward event cannot be estimated solely on the basis of a temporal relation. Comprehensive analysis of the reported adverse reactions established that serious events causally related to MMR vaccine are rare and greatly outweighed by the risks of natural MMR diseases.
Similar articles
-
Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.Pediatrics. 2002 Dec;110(6):e71. doi: 10.1542/peds.110.6.e71. Pediatrics. 2002. PMID: 12456938
-
Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.Commun Dis Intell. 2000 Feb 17;24(2):27-33. Commun Dis Intell. 2000. PMID: 10758692
-
Allergic reactions to measles-mumps-rubella vaccination.Pediatrics. 2001 Feb;107(2):E27. doi: 10.1542/peds.107.2.e27. Pediatrics. 2001. PMID: 11158501
-
Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.Vaccine. 2008 Feb 26;26(9):1166-72. doi: 10.1016/j.vaccine.2007.12.049. Epub 2008 Jan 22. Vaccine. 2008. PMID: 18255204 Review.
-
Vaccines for measles, mumps and rubella in children.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004407. doi: 10.1002/14651858.CD004407.pub2. Cochrane Database Syst Rev. 2005. PMID: 16235361 Updated. Review.
Cited by
-
Does Vaccination Increase the Risk of Autism Spectrum Disorder?Cureus. 2022 Aug 12;14(8):e27921. doi: 10.7759/cureus.27921. eCollection 2022 Aug. Cureus. 2022. PMID: 36110492 Free PMC article. Review.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD004407. doi: 10.1002/14651858.CD004407.pub5. Cochrane Database Syst Rev. 2021. PMID: 34806766 Free PMC article. Review.
-
Model Comparisons of the Cost Effectiveness of Rubella Vaccination Method in Japanese Adults.Vaccines (Basel). 2021 Mar 8;9(3):233. doi: 10.3390/vaccines9030233. Vaccines (Basel). 2021. PMID: 33800506 Free PMC article.
-
Assessing safety of Ontario's publicly funded MMR and MMRV immunization programs, 2012 to 2016.Paediatr Child Health. 2019 Apr 8;25(6):358-364. doi: 10.1093/pch/pxz037. eCollection 2020 Oct. Paediatr Child Health. 2019. PMID: 32963648 Free PMC article.
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. PMID: 32309885 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous

